CAFC-PTOSeptember 4, 2026·26-1552, 26-1922·Appeals dismissed; mandate issued September 4, 2026.
INARI MEDICAL, INC. v. IMPERATIVE CARE, INC.
Patent Trial and Appeal Board
Holding
The Federal Circuit dismissed the agreed appeals under Rule 42(b). Each side will bear its own costs.
Why It Matters
This order ends the PTAB appeals without any Federal Circuit ruling on the merits of the IPR issues.
Full Summary
INARI MEDICAL, INC. v. IMPERATIVE CARE, INC. [ORDER]
The Federal Circuit dismissed the agreed appeals under Rule 42(b). Each side will bear its own costs.
This order ends the PTAB appeals without any Federal Circuit ruling on the merits of the IPR issues.
Appeals dismissed; mandate issued September 4, 2026.
The order is nonprecedential and reflects a party-agreed dismissal.
The appeals arose from two PTAB IPR proceedings: IPR2024-01157 and IPR2025-00156.
The Federal Circuit did not address any patentability, claim construction, or other merits issue.
The court ordered each side to bear its own costs and issued the mandate the same day.
non-precedential waiver / forfeiture standing / jurisdiction claim construction
non-precedential waiver / forfeiture standing / jurisdiction claim construction
non-precedential waiver / forfeiture
Key Points
- The order is nonprecedential and reflects a party-agreed dismissal.
- The appeals arose from two PTAB IPR proceedings: IPR2024-01157 and IPR2025-00156.
- The Federal Circuit did not address any patentability, claim construction, or other merits issue.
- The court ordered each side to bear its own costs and issued the mandate the same day.
- Fed. Cir. · Oct. 6, 2026Inari Agriculture, Inc. v. Corteva Agriscience LLC
- Fed. Cir. · Oct. 5, 2026O'Reilly Winship LLC v. SnapRays LLC
- Fed. Cir. · Oct. 1, 2026Satius Holding, LLC v. Samsung Electronics Co., Ltd.
- Fed. Cir. · Sept. 30, 2026WSOU Investments LLC v. Salesforce, Inc.
- Fed. Cir. · Sept. 30, 2026TEVA PHARMACEUTICALS INTERNATIONAL GMBH v. ELI LILLY AND COMPANY